Lv21
130 积分 2025-07-08 加入
Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer
6天前
已完结
Genome-scale CRISPR-Cas9 screening stratifies pancreatic cancer with distinct outcomes and immunotherapeutic efficacy
7天前
已完结
Nanocarrier-enabled STING agonist delivery for enhanced cancer immunotherapy
7天前
已完结
Suppressing Pancreatic Cancer Survival and Immune Escape via Nanoparticle-Modulated STING/STAT3 Axis Regulation
7天前
已完结
The efficacy and safety of Nivolumab combined with Ipilimumab in the immunotherapy of cancer: a meta-analysis
25天前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
29天前
已完结
Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study
1个月前
已完结
An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer
1个月前
已完结
A single gene mutation predicts response to immune checkpoint blockade in ovarian clear cell carcinoma
1个月前
已完结
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial
3个月前
已完结
皖公网安备34019202002308
